Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial

[cafead]

via Denmark's Zealand Pharma and Boehringer Ingelheim said their experimental obesity treatment achieved up to 14.9% weight loss in a mid-stage trial, lining up a potential contestant in the booming obesity drug market.

article source